A
Arie Jan van Winkelhoff
Researcher at University Medical Center Groningen
Publications - 74
Citations - 4115
Arie Jan van Winkelhoff is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Porphyromonas gingivalis & Periodontitis. The author has an hindex of 34, co-authored 74 publications receiving 3566 citations. Previous affiliations of Arie Jan van Winkelhoff include University of Groningen & Academic Center for Dentistry Amsterdam.
Papers
More filters
Journal ArticleDOI
Systemic antibiotic therapy in periodontics.
Journal ArticleDOI
Microbiological and Clinical Results of Metronidazole Plus Amoxicillin Therapy in Actinobacillus actinomycetemcomitans-Associated Periodontitis*
TL;DR: It was concluded that mechanical periodontal treatment in combination with the metronidazole plus amoxicillin therapy is effective for subgingival suppression of A. actinomycetemcomitans in patients with severe periodontitis.
Journal ArticleDOI
Periodontitis in established rheumatoid arthritis patients: A cross-sectional clinical, microbiological and serological study
Menke J. de Smit,Johanna Westra,Arjan Vissink,Berber Doornbos-van der Meer,Elisabeth Brouwer,Arie Jan van Winkelhoff +5 more
TL;DR: Severity of periodontitis is related to severity of RA, and RA patients with severeperiodontitis have a more robust antibody response against P. gingivalis than non-RA controls, but not all RA patients have cultivable P. rheumatoid arthritis.
Journal ArticleDOI
IL-1RN gene polymorphism is associated with peri-implantitis
Marja L. Laine,Åsa Leonhardt,Ann-Marie Roos-Jansåker,A. Salvador Peña,Arie Jan van Winkelhoff,Edwin Winkel,Stefan Renvert +6 more
TL;DR: Evidence is provided that IL-1RN gene polymorphism is associated with peri-implantitis and may represent a risk factor for this disease.
Journal ArticleDOI
Antibiotic resistance in human chronic periodontitis microbiota.
TL;DR: The wide variability found in periodontal pathogen antibiotic-resistance patterns should concern clinicians empirically selecting antibiotic treatment regimens for patients with CP.